APO RESEARCH · REPORT
Allergy Immunotherapies
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
Product & engineering
Understand the product.
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
Selected research
Industry Growth & Trends
Global Allergy Immunotherapies Industry Growth and Trends Forecast to 2032
Market perspective
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
According to APO Research, the global Allergy Immunotherapies market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Read the full market overview
Report Scope
This report provides a structured, data-driven view of the global Allergy Immunotherapies market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Allergy Immunotherapies market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Allergy Immunotherapies market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Allergy Immunotherapies.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Allergy Immunotherapies market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Allergy Immunotherapies Market by Company
ALK
Stallergenes
HAL
Allergy Immunotherapies Segment by Type
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Allergy Immunotherapies Segment by Application
Allergic Rhinitis
Allergic Asthma
Other
Allergy Immunotherapies Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allergy Immunotherapies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Allergy Immunotherapies and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allergy Immunotherapies.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Allergy Immunotherapies companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Subcutaneous Immunotherapy
- Sublingual Immunotherapy
Applications
- Allergic Rhinitis
- Allergic Asthma
- Other
Companies covered
- ALK
- Stallergenes
- HAL
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Allergy Immunotherapies Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Allergy Immunotherapies Market Size by Region (2021-2032)
- 1.4.1 Global Allergy Immunotherapies Market Size by Region (2021-2026)
- 1.4.2 Global Allergy Immunotherapies Market Size by Region (2027-2032)
- 1.5 Key Regions Allergy Immunotherapies Market Size (2021-2032)
- 1.5.1 North America Allergy Immunotherapies Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Allergy Immunotherapies Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Allergy Immunotherapies Market Size Growth Rate (2021-2032)
- 1.5.4 South America Allergy Immunotherapies Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Allergy Immunotherapies Market Size Growth Rate (2021-2032)
2 Allergy Immunotherapies Market by Type
- 2.1 Type Introduction
- 2.1.1 Subcutaneous Immunotherapy
- 2.1.2 Sublingual Immunotherapy
- 2.2 Global Allergy Immunotherapies Market Size by Type
- 2.2.1 Global Allergy Immunotherapies Market Size Overview by Type (2021-2032)
- 2.2.2 Global Allergy Immunotherapies Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Allergy Immunotherapies Market Size Forecasted by Type (2027-2032)
- 2.3 Global Allergy Immunotherapies Market Size by Regions
- 2.3.1 North America Allergy Immunotherapies Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Allergy Immunotherapies Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Allergy Immunotherapies Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Allergy Immunotherapies Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Allergy Immunotherapies Market Size Breakdown by Type (2021-2026)
3 Allergy Immunotherapies Market by Application
- 3.1 Type Introduction
- 3.1.1 Allergic Rhinitis
- 3.1.2 Allergic Asthma
- 3.1.3 Other
- 3.2 Global Allergy Immunotherapies Market Size by Application
- 3.2.1 Global Allergy Immunotherapies Market Size Overview by Application (2021-2032)
- 3.2.2 Global Allergy Immunotherapies Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Allergy Immunotherapies Market Size Forecasted by Application (2027-2032)
- 3.3 Global Allergy Immunotherapies Market Size by Regions
- 3.3.1 North America Allergy Immunotherapies Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Allergy Immunotherapies Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Allergy Immunotherapies Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Allergy Immunotherapies Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Allergy Immunotherapies Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Allergy Immunotherapies Industry Trends
- 4.2 Allergy Immunotherapies Industry Drivers
- 4.3 Allergy Immunotherapies Industry Opportunities and Challenges
- 4.4 Allergy Immunotherapies Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Allergy Immunotherapies Revenue (2021-2026)
- 5.2 Global Allergy Immunotherapies Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Allergy Immunotherapies Key Company Headquarters & Area Served
- 5.4 Global Allergy Immunotherapies Company, Product Type & Application
- 5.5 Global Allergy Immunotherapies Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Allergy Immunotherapies Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Allergy Immunotherapies Players Market Share by Revenue in 2025
- 5.6.3 2025 Allergy Immunotherapies Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 ALK
- 6.1.1 ALK Company Information
- 6.1.2 ALK Business Overview
- 6.1.3 ALK Allergy Immunotherapies Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 ALK Allergy Immunotherapies Product Portfolio
- 6.1.5 ALK Recent Developments
- 6.2 Stallergenes
- 6.2.1 Stallergenes Company Information
- 6.2.2 Stallergenes Business Overview
- 6.2.3 Stallergenes Allergy Immunotherapies Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Stallergenes Allergy Immunotherapies Product Portfolio
- 6.2.5 Stallergenes Recent Developments
- 6.3 HAL
- 6.3.1 HAL Company Information
- 6.3.2 HAL Business Overview
- 6.3.3 HAL Allergy Immunotherapies Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 HAL Allergy Immunotherapies Product Portfolio
- 6.3.5 HAL Recent Developments
7 North America
- 7.1 North America Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Allergy Immunotherapies Market Size by Country (2021-2026)
- 7.3 North America Allergy Immunotherapies Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Allergy Immunotherapies Market Size by Country (2021-2026)
- 8.3 Europe Allergy Immunotherapies Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Allergy Immunotherapies Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Allergy Immunotherapies Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Allergy Immunotherapies Market Size by Country (2021-2026)
- 10.3 South America Allergy Immunotherapies Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Allergy Immunotherapies Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Allergy Immunotherapies Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst